Nanoveu Limited
NNVUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | -$0 | -$0 |
| % Growth | 31.5% | 11,046.9% | 10.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 36.3% | 63% | 90.7% | 90.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 | -$0 |
| Operating Expenses | $2 | $2 | $1 | $1 |
| Operating Income | -$2 | -$2 | -$1 | -$1 |
| % Margin | -1,082.1% | -1,080.1% | 42,212.5% | 42,194.5% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$2 | -$2 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1 | -$1 | -$1 |
| % Margin | -1,056.1% | -1,056.1% | 42,220.1% | 42,202.2% |
| EPS | -0.003 | -0.002 | -0.001 | -0.001 |
| % Growth | -33.3% | -90.9% | 8.3% | – |
| EPS Diluted | -0.003 | -0.002 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 694 | 694 | 506 | 506 |
| Weighted Avg Shares Out Dil | 694 | 694 | 506 | 506 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | -$1 | -$1 |
| % Margin | -1,051.6% | -1,060.2% | 41,801.8% | 41,488.8% |